Â鶹´«Ã½

  • By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
In the last 24 hours
The Motley Fool13:16
Simply Wall St09:39
The Business Standard08:34
Boston Globe21:14 13-Nov-24
Bisnow19:17 13-Nov-24
In the last 4 days
TipRanks08:51 11-Nov-24
PR Newswire (Press Release)20:58 10-Nov-24
Benzinga19:15 11-Nov-24
BNN Bloomberg15:37 12-Nov-24
Proactive Investors (UK)17:02 11-Nov-24
AstraZeneca (Press Release)08:17 12-Nov-24
FierceBiotech11:50 12-Nov-24
FiercePharma15:52 12-Nov-24
Insider Media09:10 12-Nov-24
Scrip Pharma Intelligence15:55 12-Nov-24
Evening Standard10:27 12-Nov-24
TIME12:11 12-Nov-24
FiercePharma15:16 13-Nov-24
London South East10:03 12-Nov-24
TipRanks08:46 12-Nov-24
AstraZeneca (Press Release)08:07 12-Nov-24
Investment Monitor10:44 13-Nov-24
PMLiVE13:26 13-Nov-24
Pharmaceutical Business Review12:52 13-Nov-24
Clinical Trials Arena12:36 13-Nov-24
pharmaphorum08:41 13-Nov-24
TipRanks05:27 13-Nov-24
Scrip Pharma Intelligence17:57 12-Nov-24
ENDPOINTS21:46 12-Nov-24
Fortune10:53 12-Nov-24
In the last 7 days
Motley Fool (UK)17:50 8-Nov-24
This is Money11:02 8-Nov-24
BNN Bloomberg11:21 8-Nov-24
Hong Kong Free Press07:43 8-Nov-24
This is Money23:00 9-Nov-24
Scrip Pharma Intelligence11:45 9-Nov-24
Scrip Pharma Intelligence11:45 9-Nov-24
ShareCast08:41 8-Nov-24
Seeking Alpha23:12 7-Nov-24
City AM14:01 10-Nov-24
Yahoo! UK & Ireland16:54 8-Nov-24
Caixin Global04:07 8-Nov-24
Scrip Pharma Intelligence19:05 7-Nov-24
FXstreet20:07 8-Nov-24
Simply Wall St18:50 8-Nov-24
Business Wire (Press Release)14:03 8-Nov-24
AllAfrica13:21 8-Nov-24
Proactive Investors (UK)13:16 8-Nov-24
pharmaphorum12:01 8-Nov-24
AsiaOne11:43 8-Nov-24
London South East10:23 8-Nov-24
Proactive Investors (UK)09:01 8-Nov-24
TipRanks08:34 8-Nov-24
In the last 14 days
Proactive Investors (UK)15:32 5-Nov-24
Proactive Investors (UK)14:21 5-Nov-24
Proactive Investors (UK)13:46 6-Nov-24
Barchart16:35 4-Nov-24
Zacks20:37 6-Nov-24
TipRanks16:10 1-Nov-24
Proactive Investors (UK)13:31 5-Nov-24
Bloomberg Law09:39 5-Nov-24
Motley Fool (UK)10:13 6-Nov-24
BNN Bloomberg15:59 6-Nov-24
Proactive Investors (UK)16:49 6-Nov-24
Law36019:45 1-Nov-24
People's Daily04:41 1-Nov-24
FiercePharma21:22 5-Nov-24
AsiaOne09:44 7-Nov-24
Sinocism01:53 5-Nov-24
South China Morning Post10:26 4-Nov-24
The Motley Fool12:47 3-Nov-24
Motley Fool (UK)08:35 2-Nov-24
Scrip Pharma Intelligence15:17 1-Nov-24
Mint19:33 4-Nov-24
Proactive Investors (UK)13:31 7-Nov-24
Proactive Investors (UK)17:14 5-Nov-24
Hong Kong Standard20:13 31-Oct-24
Financial Mail19:17 6-Nov-24

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.